US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

4 deals · US$11bndisclosed · Dermatology · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Feb 2026 Wilmington Dermatology Center –DermCare ManagementAcquisitionCompleted–Dermatology+2 Capstone Partners (sell-side)
May 2026 Replay –LEO PharmaAcquisitionAnnounced50.0Biotech+2 Latham & Watkins (buy-side)
Jun 2026 Obagi Medical dermatological skincare and aesthetics business WaldencastBridgepointAsset saleAnnounced–Skin Care+2 LazardLatham & Watkins (buy-side)
Jun 2026 Apogee Therapeutics –AbbVieAcquisitionPending10,900.0Biotech+2 Goldman Sachs (sell-side)Jefferies (sell-side)Kirkland & Ellis (sell-side)Paul, Weiss (buy-side)Morgan Stanley (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built